SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-033761
Filing Date
2024-02-13
Accepted
2024-02-13 16:22:56
Documents
16
Period of Report
2024-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750746d8k.htm   iXBRL 8-K 38306
2 EX-99.1 d750746dex991.htm EX-99.1 21720
6 GRAPHIC g750746g0209235112679.jpg GRAPHIC 4500
  Complete submission text file 0001193125-24-033761.txt   202939

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20240213.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20240213_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20240213_pre.xml EX-101.PRE 11277
18 EXTRACTED XBRL INSTANCE DOCUMENT d750746d8k_htm.xml XML 3686
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 24626359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)